West Pharmaceutical Services Income Statement
Revenue, expenses, and profitability over time
West Pharmaceutical Services generated $3.2B in trailing twelve-month revenue, up 0.1% year-over-year. Net income was $542.7M with a 16.85% net margin. Gross margin stands at 36.28% and operating margin at 20.34%. Diluted EPS is $7.48, which grew 0.2% year-over-year. Based on the Q1 2026 filing.
Latest FilingQ1 2026
Report Date2026-04-23
Market Cap$23.3B
P/E Ratio43.00
ROE19.13%